Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Argus Health
Deloitte
Federal Trade Commission
Boehringer Ingelheim

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 7,666,831

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,666,831
Title:Methods of treatment using specific binding agents of human angiopoietin-2
Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
Inventor(s): Oliner; Jonathan Daniel (Newbury Park, CA), Min; Hosung (Newbury Park, CA)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Application Number:11/499,902
Patent Claims:see list of patent claims

Details for Patent 7,666,831

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 003 2001-11-14 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,666,831

Country Patent Number Publication Date
South Africa 200402394 Dec 10, 2004
Yugoslavia 37304 Aug 17, 2006
World Intellectual Property Organization (WIPO) 03057134 Apr 29, 2004
World Intellectual Property Organization (WIPO) 03057134 Aug 19, 2004
World Intellectual Property Organization (WIPO) 03057134 Jul 17, 2003
World Intellectual Property Organization (WIPO) 2004092215 Apr 14, 2005
World Intellectual Property Organization (WIPO) 2004092215 Oct 28, 2004
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Accenture
Citi
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.